As a global player in microorganisms and fermentation, Lesaffre is continuing to invest in research and development as part of its activities in favour of human and animal health. The company has invested in new equipment to continue developing its…
In a survey carried out between August and October 2019 among consumers in seven different countries[1], Lesaffre, a global player in fermentation, shows that people around the world do not all have the same knowledge and appreciation of the five…
Lesaffre and Recombia Biosciences to Advance Innovative Gene Editing technology through a strategic partnership Recombia Biosciences aims to harness its proprietary genome editing technologies to accelerate the development of yeast for sustainable production of fermented ingredients. For the next few…
On 19th of September, at the end of its annual general meeting, Lesaffre’s Board of Directors elected Thibaut de Ladoucette as Chairman, to replace Lucien Lesaffre, Chairman of the Board of Directors since 2012 and having reached the statutory age…
As a global key player recognized for its expertise in the field of yeast and yeast extracts, Lesaffre has been developing for several years in the world of micro-organisms and fermentation. Today, the group is unveiling a new territory of…
Pursuing its expansion strategy on Chinese market, Lesaffre, global key player in the field of yeasts and fermentation, has concluded a majority shareholding in Biohymn Biotechnology; a Chinese company specialized in the production of yeast and yeast extracts. This operation…
